论文部分内容阅读
目的：探讨他汀类联合心血管药物治疗冠心病的临床疗效。方法回顾性分析2014年10月－2014年12月来我院就诊的63例冠心病患者，将其随机分为实验组和对照组，对照组患者31例，服用普通心血管药物进行治疗，实验组患者32例，在对照组患者服用普通心血管药物基础上加服他汀类药物进行治疗，比较两组患者的临床疗效。结果对照组总有效率为80．65％，实验组总有效率为93．75％，两组比较，对照组总有效率明显低于实验组，差异有统计学意义（P ＜0．05）。治疗后对照组患者血脂指标（HDL －C（高密度脂蛋白胆固醇）、LDL －C（低密度脂蛋白胆固醇）、甘油三酯等）下降率明显高于对照组，差异有统计学意义（P ＜0．05）。结论冠心病的发病原因为大量物质沉积于血管，造成血管直径减少，血流流量减少。他汀类联合心血管类药物治疗冠心病疗效显著，危险性小，不良反应少，且能改善血脂粘稠的问题，值得应用和推广。“,”objective:To discuss Statins joint clinical curative ef ect of cardiovascular drug treatment of coronary heart disease.Methods a retrospective analysis in October 2014 -De-cember 2014 to our hospital 63 cases of coronary heart disease patients,randomly divided into experimental group and the control group,control group patients with 31 cases,common cardiovas-cular drugs for treatment,the experimental group 32 cases of patients,patients in the control group on the basis of common cardiovascular drugs take a statin treatment,compare the clinical ef i-cacy of two groups of patients.Results the control group total ef ective rate was 80.65%,the total ef ective rate was 93.75%,comparing the two groups,control group total ef ective rate signifi-cantly lower than that of the experimental group,the dif erence was statistical y significant (P <0.05).The control group after treatment in patients with blood lipid index (HDL -C (high density lipoprotein cholesterol),LDL -C (low density lipoprotein cholesterol)and triglycerides)decline rate is significantly higher than the control group,the dif erence was statistical y signif-icant (P <0.05).Conclusion the etiology of coronary heart disease for a large number of material deposition in the blood vessels,resulting in a decrease of blood vessel diameter,blood flow rate to decrease.Statins with cardiovascular drugs therapy of coronary heart disease curative ef ect is distinct,the risk is smal ,less adverse reaction,and can improve the blood lipid sticky prob-lem,worthy of application and promotion.